Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Povetacicept by Alpine Immune Sciences for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura): Likelihood of Approval
Povetacicept is under clinical development by Alpine Immune Sciences and currently in Phase II for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic...
Povetacicept by Alpine Immune Sciences for IgA Nephropathy (Berger's Disease): Likelihood of Approval
Povetacicept is under clinical development by Alpine Immune Sciences and currently in Phase III for IgA Nephropathy (Berger's Disease). According...
Povetacicept by Alpine Immune Sciences for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis): Likelihood of Approval
Povetacicept is under clinical development by Alpine Immune Sciences and currently in Phase II for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA...
Povetacicept by Alpine Immune Sciences for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura): Likelihood of Approval
Povetacicept is under clinical development by Alpine Immune Sciences and currently in Phase II for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic...
Povetacicept by Alpine Immune Sciences for IgA Nephropathy (Berger's Disease): Likelihood of Approval
Povetacicept is under clinical development by Alpine Immune Sciences and currently in Phase III for IgA Nephropathy (Berger's Disease). According...